BACKGROUND: Self-expanding metallic stent (SEMS) placement is an important method of dysphagia palliation for patients with inoperable esophageal cancer. In most institutions, it is performed with fluoroscopic guidance; however, in 2001, we described a novel, direct-vision approach to SEMS placement, which does not require fluoroscopy. Here we report an audit of our experience over the last 5 years when using this methodology. OBJECTIVE: To describe our 5-year experience of 98 patients in whom esophageal stents were inserted when using the direct-vision technique and compare outcomes with published series of radiography-guided stents. DESIGN: Retrospective review of single-center experience. SETTING: English National Health Service Cancer Centre Hospital. PATIENTS: All patients who underwent esophageal stent insertion for a primary esophageal malignancy. INTERVENTIONS: SEMS insertion by direct endoscopic vision. RESULTS: Ninety-eight patients underwent SEMS insertion for malignant dysphagia during the study period, 92% of which were inserted without fluoroscopy. The technique had a low complication rate, which was consistent with published fluoroscopic data, and the median survival beyond stent insertion was 100 days (interquartile range, 62, 256; range, 4-921 days). In 59 patients, no further endoscopic palliative procedure was required. LIMITATIONS: Retrospective data collection. CONCLUSIONS: This series confirms direct-vision SEMS placement as a safe and efficacious method of malignant dysphagia palliation, providing definitive treatment in almost two thirds of cases.
BACKGROUND: Self-expanding metallic stent (SEMS) placement is an important method of dysphagia palliation for patients with inoperable esophageal cancer. In most institutions, it is performed with fluoroscopic guidance; however, in 2001, we described a novel, direct-vision approach to SEMS placement, which does not require fluoroscopy. Here we report an audit of our experience over the last 5 years when using this methodology. OBJECTIVE: To describe our 5-year experience of 98 patients in whom esophageal stents were inserted when using the direct-vision technique and compare outcomes with published series of radiography-guided stents. DESIGN: Retrospective review of single-center experience. SETTING: English National Health Service Cancer Centre Hospital. PATIENTS: All patients who underwent esophageal stent insertion for a primary esophageal malignancy. INTERVENTIONS: SEMS insertion by direct endoscopic vision. RESULTS: Ninety-eight patients underwent SEMS insertion for malignant dysphagia during the study period, 92% of which were inserted without fluoroscopy. The technique had a low complication rate, which was consistent with published fluoroscopic data, and the median survival beyond stent insertion was 100 days (interquartile range, 62, 256; range, 4-921 days). In 59 patients, no further endoscopic palliative procedure was required. LIMITATIONS: Retrospective data collection. CONCLUSIONS: This series confirms direct-vision SEMS placement as a safe and efficacious method of malignant dysphagia palliation, providing definitive treatment in almost two thirds of cases.
Authors: L M Almond; K Patel; L Keast; J Hodson; R Nijjar; P G Wilson; M Richardson; R Singhal Journal: Surg Endosc Date: 2016-09-09 Impact factor: 4.584
Authors: Stephen Kucera; James Barthel; Jason Klapman; Ravi Shridhar; Sarah Hoffe; Cynthia Harris; Khaldoun Almhanna; Kenneth Meredith Journal: J Gastrointest Oncol Date: 2016-06
Authors: Saurabh Chandan; Babu P Mohan; Shahab R Khan; Neil Bhogal; Andrew Canakis; Mohammad Bilal; Amaninder S Dhaliwal; Muhammad Aziz; Harmeet S Mashiana; Shailender Singh; Wade Lee-Smith; Suresh Ponnada; Ishfaq Bhat; Douglas Pleskow Journal: Endosc Int Open Date: 2020-06-16
Authors: Michael Mwachiro; Robert Parker; Justus Lando; Ian Simel; Nyail Chol; Sinkeet Ranketi; Robert Chepkwony; Linus Pyego; Caren Chepkirui; Winnie Chepkemoi; David Fleischer; Sanford Dawsey; Mark Topazian; Steve Burgert; Russell White Journal: Endosc Int Open Date: 2022-04-14